Overview
- 4 inspections across 4 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-08-24.
At a glance
Inspections
4
Sites
4
Observations
0
Career since
May 2011
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Novo Nordisk US Bio Production Inc. | 24 Aug 2018 | Biologics | On file |
| Merck Sharp & Dohme LLC | 26 Jun 2015 | Biologics | On file |
| GSK Vaccines GmbH | 27 Mar 2012 | On file | |
| Cangene BioPharma, LLC. | 27 May 2011 | On file |
Sites inspected
Novo Nordisk US Bio Production Inc.West Lebanon, United States1 insp.
Merck Sharp & Dohme LLCWest Point, United States1 insp.
GSK Vaccines GmbHMarburg, Germany1 insp.
Cangene BioPharma, LLC.Rockville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Andrey G Sarafanov1 shared
Obinna R Echeozo1 shared
Hector A Carrero1 shared
Michele L Forster1 shared
Jeremy L Wally1 shared
Pankaj H Amin1 shared
Nawab A Siddiqui1 shared
Marion Michaelis1 shared
Full investigator report
Get the verbatim findings behind Ellen Huang's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site